CCDC39 Gene Primary Ciliary Dyskinesia Type 14 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Primary Ciliary Dyskinesia
The CCDC39 Gene Primary Ciliary Dyskinesia Type 14 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for individuals suffering from chronic respiratory conditions and unexplained fertility issues. This advanced test specifically targets mutations in the CCDC39 gene, which plays a critical role in the proper functioning of cilia – microscopic hair-like structures that line the respiratory tract and reproductive organs.
What Does This Test Measure?
This sophisticated genetic analysis utilizes Next-Generation Sequencing (NGS) technology to comprehensively examine the CCDC39 gene for pathogenic variants that cause Primary Ciliary Dyskinesia Type 14. The test specifically detects:
- Point mutations and single nucleotide variants in the CCDC39 gene
- Small insertions and deletions affecting gene function
- Copy number variations that may impact ciliary structure
- Genetic variants associated with impaired mucociliary clearance
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Chronic respiratory infections beginning in infancy or childhood
- Recurrent sinusitis and persistent nasal congestion
- Chronic middle ear infections and hearing problems
- Unexplained infertility or subfertility in males
- Situs inversus (organs positioned on opposite sides)
- Family history of primary ciliary dyskinesia
- Chronic bronchitis or bronchiectasis without clear cause
Clinical Benefits of Genetic Testing
Undergoing the CCDC39 gene test provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out Primary Ciliary Dyskinesia Type 14
- Personalized Treatment: Guides targeted respiratory management strategies
- Family Planning: Provides crucial information for genetic counseling
- Early Intervention: Enables proactive management of respiratory complications
- Disease Monitoring: Helps track disease progression and treatment response
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors and ENT specialists. Results typically fall into three categories:
- Positive Result: Indicates the presence of pathogenic CCDC39 gene mutations confirming Primary Ciliary Dyskinesia Type 14 diagnosis
- Negative Result: Suggests no detectable mutations in the CCDC39 gene, though other genetic causes may need investigation
- Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further evaluation
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified genetic testing centers ensures accessibility and convenience for patients nationwide.
Take Control of Your Health Today
Don’t let unexplained respiratory symptoms or fertility concerns remain unanswered. The CCDC39 Gene Primary Ciliary Dyskinesia Type 14 NGS Genetic DNA Test provides the clarity you need for proper diagnosis and management. Our team of genetic specialists and ENT doctors are ready to guide you through the testing process and help interpret your results.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward understanding your genetic health.
